Creating new perspectives in healthcare
We are driven by the purpose of improving lives through pharmaceutical innovation. Knowing that our knowledge and expertise can concretely improve people’s health and well-being, we strive every day to improve healthcare by researching and developing innovative solutions for disease prevention and management. Our daily work is inspired by the firm belief that everyone deserves access to healthcare that empowers them to live their lives to the fullest.
Our Mission
Italfarmaco group is a leading organisation that specialises in the development, manufacture, and marketing of prescription and non-prescription products. Our primary objective is to increase our investment in research and development activities, with a particular focus on developing high-quality, effective solutions for patients and healthcare providers worldwide. We are also committed to developing innovative treatments for specialty and rare diseases. Our organisation is dedicated to excellence and we work to achieve sustainable growth and have a positive impact on society and the environment.
Our Values
Meet our Leaders
-
Affiliate
-
Distribution / Licence agreements
A glance at our value
FCST GROSS
SALES 2024
PROPRIETARY
PRODUCTS
INVESTMENT IN MANUFACTURING
(2020-2024)
PRODUCT INDUSTRIAL
UNITS PER YEAR
Our production plants
We oversee the entire process of creating drugs, from start to finish, to ensure their quality as medicines. We have six advanced production facilities; in each, we manufacture different products: injectable and solid oral products in Milan; liquid oral products in Madrid and Santiago de Chile; semi-solid products in Barcelona; API products in Frosinone (Italy) and Salvador de Bahia manufacture. We also have Chemi Spa, an Italian pharmaceutical chemical company that produces complex molecules, including the synthesis of the active ingredient (API) and the pharmaceutical form of injectable drugs.
We continuously invest in technology to maintain modern, flexible facilities, a high production capacity, quality, safety, and environmental sustainability, as modern disease solutions require a contemporary approach.
